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Oral streptococci are the major group of microbes isolated from oral microﬂora.
They represent frequent pathogens of infective endocarditis (IE), and it is assumed that
in most of the cases oral streptococci are acquired via mucosa layer of oral cavity.
Staphylococcus aureus is also frequently isolated from IE as it accounts for 20%–30%
of all cases. Vancomycin has been the most reliable therapeutic agent against
infections caused by methicillin-resistant S. aureus (MRSA). The main objective of
this study was to examine the occurrence of S. aureus species in dental caries
specimens. Antimicrobial susceptibility testing of S. aureus to four antibiotics namely
vancomycin, linezolid, teicoplanin, and daptomycin was performed. Detection of
vancomycin resistance was conducted using polymerase chain reaction. Among the
tested 150 strains, 98 were MRSA and of that 54 were vancomycin sensitive and 27
were resistant. All 98 MRSA strains were positive for mecA and 36 yielded pvl,
whereas 13 carried vanA and only 2 were positive for vanB. Majority of the isolates
showed sensitivity toward daptomycin and linezolid. Strains of S. aureus exhibiting
decreased susceptibility to different antibiotics like vancomycin, daptomycin, and
linezolid severely compromise the therapeutic alternatives and require a considerable
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amount of time, public awareness, and integrative health-care strategies to prevent the
emergence of resistance to these compounds.
Keywords: antibiotic resistance, multidrug-resistant bacteria, S. aureus, vanA,
dental caries, S. aureus, antibiotics, vancomycin resistant
Introduction
Multidrug-resistant strains are arising worldwide. They have become a
menace, which requires more attention and a driving force to eradicate them.
Methicillin-resistant Staphylococcus aureus (MRSA) has been of increased
concern and a major pathogen of hospital-acquired infections [1, 2]. Vancomycin
was considered to be the best alternative for the treatment of multidrug-resistant
MRSA. However, there have been increasing reports of vancomycin-resistant S.
aureus (VRSA) strains exhibiting two different resistance mechanisms [3, 4]. Over
the past two decades, vancomycin has been the drug of choice for MRSA, but
recent studies have indicated the therapeutic failure of vancomycin against MRSA
isolates. It has aroused global concern since only a limited number of effective
therapeutics are currently available against MRSA [5, 6]. There have been reports
of MRSA encoding both mecA and mecC confer resistance to β-lactams and
poses diagnostic problems [7]. In various studies, it has been noted that MRSA
strains were also resistant to one or more non-β-lactam antibiotics and some of
them were multidrug-resistant [8]. Oral streptococci are the major group of
microbes isolated from oral microﬂora and they are frequently isolated patho-
gens from infective endocarditis (IE). One of the clinical importance of dental
caries is the inimitable site for these bacteria to enter bloodstream and increases
chances to infect heart. Therefore, dental procedures and dental hygiene have
been given much more attention to the predisposing conditions and to prevent
streptococcal IE [9].
Besides streptococci, reports suggest a high incidence of Staphylococcus
species in IE. Among them, S. aureus is the most frequently isolated bacterium,
which accounts for 20%–30% of all IE cases [10, 11]. Though inﬂuencing
conditions and route of infections related to staphylococcal IE are not indicated.
However, in most of cases, it is assumed that it is acquired via a mucosal surface or
percutaneous route, particularly in cases associated with nosocomial infection [12].
Staphylococci are main inhabitant of skin, as well as glands of skin. These
are also found to be brieﬂy resident in the oral cavity and it is speculated that IE
cases caused by them are originated in the oral cavity [13].
In this study, we examined the occurrence of S. aureus in dental caries
specimens. In addition, in view of the abovementioned circumstances, sensitivity
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patterns of S. aureus to four different antibiotics – vancomycin, linezolid, teico-
planin, and daptomycin were analyzed. The prevalence of vancomycin resistance
was detected using polymerase chain reaction (PCR).
Materials and Methods
Bacterial isolates
A total of 150 S. aureus isolates were obtained from dental caries clinical
samples from the patients who were visited the facilities of dental hospitals clinic.
The morphology and characteristics of S. aureus strains were studied using Gram
staining, hemolysis on blood agar, DNase, catalase, coagulase tests, and fermen-
tation of mannitol. The study was designed and permitted by the Institutional
Ethics Committee and a written informed consent was obtained from every
individual before the sample collection.
Phenotypic methods for detection of MRSA
All the isolates were subjected to disk diffusion susceptibility testing to
oxacillin (1 μg) and cefoxitin (30 μg) disks for detection of methicillin resistance.
Growth on oxacillin screen agar containing 6 μg/ml of oxacillin was also checked
on all the isolates. MRSA (ATCC 43300) was used as positive control and
S. aureus (ATCC 25923) as negative control. MRSA strains were further tested.
Determination of minimum inhibitory concentration (MIC)
MIC was determined based on Clinical and Laboratory Standards Institute
guidelines. Brieﬂy, gradient plates of Mueller–Hinton agar (Hi Media Laboratories,
Mumbai, India) were prepared with vancomycin, daptomycin, teicoplanin, and
linezolid (0.5–256 μg/ml, Sigma-Aldrich). An amount of 0.5 McFarland equivalent
inoculum prepared using 18- to 24-h-old culture was spotted on to gradient plates
and the plates were incubated overnight at 35 °C for 24 h to achieve visible growth.
PCR ampliﬁcation for all vancomycin-resistant genes
A single target PCR was carried out to detect the presence of genes encoding
vancomycin resistance. Of the many genotypes of vancomycin resistance de-
scribed in enterococci, attempt was made to identify the commonest ones, PCR
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ampliﬁcation of the vanA gene was performed using GeneAmp thermal cycler
(Applied Biosystems, Wilmington, NC, USA).
PCR for MRSA detection
mecA gene encoding methicillin resistance and pvl gene presented in
community-associated MRSA strains were tested in all the 98 MRSA isolates
using the primers given in Table I.
The ampliﬁcation conditions maintained were initial denaturation at 98 °C
for 10 s, annealing for 1 min at different temperature respective to target PCR,
polymerization was performed at 72 °C for 1 min, and ﬁnally extension at 72 °C
for 5 min.
Results and Discussion
During the study period, a total number of 150 isolates were collected from
dental caries clinical samples. Altogether 98 were found to be MRSA by disk
diffusion test. Among the 98 patients, 59 of them had prolonged hospital stay of
longer than 10-day duration, 42 patients had postoperative dental infections, and
29 patients were admitted due to dental infections for more than 2 days. In all,
71 patients were males and 27 patients were females.
The results of MIC for 98 isolates showed vancomycin was<2 μg/ml in case
of 54 isolates and 27 isolates showed intermediate resistance in the range of
4–8 μg/ml, whereas 15 isolates showed MIC in the range of 16–128 μg/ml
indicating that these were VRSA. Detailed results are shown in Table II.
By PCR ampliﬁcation, mecA gene was present in all the 98 isolates of
MRSA and pvl gene was present in 36 isolates. vanA gene was present in
13 isolates, and only 2 were vanB-positive (Figure 1).
Table I. List of primers used in this study
Gene Forward Reverse Reference
vanA AATAGCGCGGACGAATTGGAC AACGCGGCACTGTTTCCCAA [14]
vanB CTTAACGCTGCGATAGAAGC CTGATGGATGCGGAAGATAC [14]
vanD TTTGTAAAGCCTGCCCGTTC CCAAGTAYCCGGTAAATCTTC [14]
vanE AAATAATGCTCCATCAATTTGCTGA ATAGTCGAAAAAGCCATCCACAAG [14]
vanG TTGGAGGCAATTCAACAGAGT TCGCAGCCAACAACAGGTATT [14]
mecA GTAGAAATGACTGAACGTCCGATAA CCAATTCCACATTGTTTCGGTCTAA [15]
pvl ATCATTAGGTAAAATGTCTGGACATGA GCATCAASTGTATTGGATAGCAAAAGC [15]
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Table II. List of positive isolates with their antibiogram and PCR results
Isolates
Vancomycin-
resistant gene Resistance Susceptibility
VRSA1 vanB Vancomycin Daptomycin, linezolid, and
teicoplanin
VRSA2 vanA Daptomycin, vancomycin, and teicoplanin Linezolid
VRSA3 vanA Daptomycin, vancomycin, and teicoplanin Linezolid
VRSA4 vanA Vancomycin and teicoplanin Linezolid and daptomycin
VRSA5 vanA Vancomycin, daptomycin, and teicoplanin Linezolid
VRSA6 vanB Vancomycin Linezolid, daptomycin, and
teicoplanin
VRSA7 vanA Vancomycin and teicoplanin Linezolid and daptomycin
VRSA8 vanA Vancomycin and teicoplanin Linezolid and daptomycin
VRSA9 vanA Vancomycin and teicoplanin Linezolid and daptomycin
VRSA10 vanA Vancomycin and teicoplanin Linezolid and daptomycin
VRSA11 vanA Vancomycin and teicoplanin Linezolid and daptomycin
VRSA12 vanA Vancomycin, daptomycin, and teicoplanin Linezolid
VRSA13 vanA Vancomycin, daptomycin, and teicoplanin Linezolid
VRSA14 vanA Vancomycin, daptomycin, and teicoplanin Linezolid
VRSA15 vanA Vancomycin, daptomycin, and teicoplanin Linezolid
Figure 1. PCR ampliﬁcation of vanA and vanB genes
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For remaining antibiotics, the range of MIC was <1 g/ml for daptomycin,
<8 g/ml for teicoplanin, and <4 g/ml for linezolid and it was found that majority of
the isolates showed sensitivity toward daptomycin and linezolid antimicrobials
and only few were resistant isolates. The isolates, which were vanA-positive, have
been illustrated in Table I. All these isolates were found to be highly resistant to all
the antibiotics, which were tested in this study.
The rising risk of MRSA strains has proved to be a great problem globally
and a positive and healthy approach has to be taken to combat this disease scourge.
Vancomycin has been the most reliable therapeutic agent against infections caused
by MRSA. A certain group of S. aureus, designated hetero-VRSA, frequently
generate VRSA upon exposure to vancomycin, and are associated with infections
that are potentially refractory to vancomycin therapy [16]. Although vanA-positive
isolates have been found earlier in enterococci, but presence of vanA gene in
S. aureus poses a great challenge, and it is considered to be due to conjugative
transfer of the gene from enterococci to S. aureus during hospital-acquired
infections [17].
S. aureus is the most commonly isolated Staphylococcus species in IE cases
[18, 19], Staphylococcus epidermidis and Staphylococcus lugdunensis are also
predominant causative agents of IE [11, 19], and aggressive clinical courses with
high mortality [20]. Both S. aureus and S. epidermidis are found in patients with
dental infection (particularly abscess); however, the possible presence of S. aureus
is especially important in dental care due to its increased resistance. Earlier
literature states that S. aureus ampliﬁed signiﬁcantly after surgical induction of
hyposalivation [14].
Among collected 150 isolates, 98 (65.3%) were MRSA and 42 (28%) were
resistant to vancomycin. All 98 MRSA isolates were positive for mecA gene and
only 13 (8.6%) and 2 (2.13%) harbored vanA and vanB, respectively. About 13
patients had vanA-positive strains, which indicate that recommended infection
control strategies worked and prevented further spread to other patients, but still
the exact mechanism of pathogenesis remains unknown. Most of the VRSA strains
were also oxacillin or methicillin resistant (MRSA).
Conclusions
Strains of S. aureus exhibiting decreased susceptibility or resistance to
vancomycin, daptomycin, and linezolid severely compromise the therapeutic
alternatives for life-threatening MRSA infections. Strategies to prevent emer-
gence of resistance to these compounds in MRSA appear to be tough: ﬁrst,
an adequate decrease in the bacterial load by timely surgical drainage of
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collections and second, optimization of the pharmacological parameters of the
antibiotics in speciﬁc clinical situations. An additional strategy could be a
combination of treatments used against the widespread evolution of MRSA
strains. Vancomycin resistance is thought to be due to increased overuse of the
antibiotic in cases such as in pseudomembranous colitis or it may be due to
certain changes in the bacterial cell wall structure such as thickening of the cell
wall or changes in the site of action of the glycopeptides [15]. Preventing the
scourge of multidrug-resistant strains particularly MRSA and VRSA will
require a considerable amount of time, public awareness, and an integrative
health-care approach.
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